Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 28,892 shares at $21.78 ($629K) on 2025-06-04, disclosed to the SEC on 2025-06-05.
Open-market sale of $629k ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.78 | 14,446 | $315K | 50.0% |
| 2 | $21.78 | 14,446 | $315K | 50.0% |
| Total | $21.78 avg | 28,892 | $629K | 100% |
| Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |
| PCRX | SELL | 2023-04-05 | $285K | — | Filing → |